MSH|^~\&|LAB|Dynacare|||20240604113019-0400||ORU^R01|21247370|D|2.3|||||||enCA
PID|1||2222225892^^^^JHN^~9J6MU8QPE0^^^^^~^^^^XXOEI^||ITTESTING^STG5892M^5982M||19660322|F|||32 CANELLI HEIGHTS COURT^^THORNHILL^ON^L6T5M3^||^|||||
ORC||^Dynacare|5010021687||IP||||20240604084348-0400||||||||^ONLY^DYNA
OBR|1|^Dynacare|5010021687|139M^IRON^DYNA|||20240604084300-0400|||||||20240604084348-0400|^^^^|699999^ONLY^TEST^^^^^^DYNA|||9J6MU8QPE0|CHEM|114461|20240604111219-0400|||F|^^||
OBX|1|NM|139M^IRON^DYNA|114461|10.|umol/L|6 - 27|N|||F|||20240604111219-0400
NTE|1|RF|6 - 27   umol/L|RF^^^
OBR|2|^Dynacare|5010021687|139N^TIBC^DYNA|||20240604084300-0400|||||||20240604084348-0400|^^^^|699999^ONLY^TEST^^^^^^DYNA|||9J6MU8QPE0|CHEM|114484|20240604111226-0400|||F|^^||
OBX|1|NM|139N^TIBC^DYNA|114484|36.|umol/L|45 - 77|L|||F|||20240604111226-0400
NTE|1|RF|45 - 77   umol/L|RF^^^
OBR|3|^Dynacare|5010021687|139O^SATURATION^DYNA|||20240604084300-0400|||||||20240604084348-0400|^^^^|699999^ONLY^TEST^^^^^^DYNA|||9J6MU8QPE0|CHEM|114504|20240604111226-0400|||F|^^||
OBX|1|NM|139O^SATURATION^DYNA|114504|0.28||0.2 - 0.5|N|||F|||20240604111226-0400
NTE|1|RF|0.20 - 0.50 /1|RF^^^
OBR|4|^Dynacare|5010021687|329^FERRITIN^DYNA|||20240604084300-0400|||||||20240604084348-0400|^^^^|699999^ONLY^TEST^^^^^^DYNA|||9J6MU8QPE0|CHEM|114545|20240604111236-0400|||F|^^||
OBX|1|NM|329^FERRITIN^DYNA|114545|51.|ug/L|12 - 223|N|||F|||20240604111236-0400
NTE|1|RS||RS^^DYNA^3292
NTE|2|RS|In patients with concomitant inflammation, use Iron|RS^^DYNA^3292
NTE|3|RS|studies, including TIBC and Transferrin Saturation, to|RS^^DYNA^3292
NTE|4|RS|assess Iron Deficiency status.|RS^^DYNA^3292
NTE|5|RS|In absence of concomitant inflammation, Ferritin levels can|RS^^DYNA^3292
NTE|6|RS|be interpreted as follows:|RS^^DYNA^3292
NTE|7|RS|30-50: Probable iron deficiency|RS^^DYNA^3292
NTE|8|RS|51-100: Possible iron deficiency, if risk factors are|RS^^DYNA^3292
NTE|9|RS|present|RS^^DYNA^3292
NTE|10|RS|101-300: Iron deficiency unlikely|RS^^DYNA^3292
NTE|11|RS|For guidance, see www.hemequity.com/raise-the-bar|RS^^DYNA^3292
NTE|12|RF|12 - 223  ug/L|RF^^^
OBR|5|^Dynacare|5010021687|HRPT^HEPATITIS TESTING:^DYNA|||20240604084300-0400|||||||20240604084348-0400|^^^^|699999^ONLY^TEST^^^^^^DYNA|||9J6MU8QPE0|CHEM|700390|20240604112356-0400|||F|^^||
OBX|1|TX|HRPT^HEPATITIS TESTING:^DYNA|700390|See Notes|||I|||F|||20240604112356-0400
NTE|1|RS|A value of 10 U/L or greater is consistent with immunity.|RS^^DYNA^HB2R
OBX|2|TX|HMRK^ADD'L MARKERS  \E\HMRK^DYNA|700390.029|HEPATITIS MARKERS - INDIVIDUALLY REQUESTED                                 \.br\       ------------------------------------------|||I|||F|||20240604112356-0400
OBX|3|TX|HB1^HBsAg Screen \E\HB1?^DYNA|700390.030|HBs ANTIGEN SCREEN                                       NEG|||N|||F|||20240604112356-0400
OBX|4|TX|HB2^anti HBS     \E\HB2?^DYNA|700390.032|HBs ANTIBODY                                             NEG|||N|||F|||20240604112356-0400
OBX|5|NM|HB2UL^U/L for anti HBS^DYNA|700390.033|9.9|U/L|10 - 100|H|||F|||20240604112356-0400
OBX|6|TX|HA1^anti HAV     \E\HA1?^DYNA|700390.040|HAV TOTAL ANTIBODY                                       POS       POS|||A|||F|||20240604112356-0400
OBX|7|TX|HPC^anti HCV     \E\HPC?^DYNA|700390.042|HCV ANTIBODY                                             NEG|||N|||F|||20240604112356-0400
OBR|6|^Dynacare|5010021687|ENAD^ENA AB SCREENING^DYNA|||20240604084300-0400|||||||20240604084348-0400|^^^^|699999^ONLY^TEST^^^^^^DYNA|||9J6MU8QPE0|IMMUN|401100|20240604112147-0400|||P|^^||
OBX|1|TX|ENAD^ENA AB SCREENING^DYNA|401100|POSITIVE||NEGATIVE|A|||P|||20240604112147-0400
NTE|1|RF|NEGATIVE|RF^^^
OBR|7|^Dynacare|5010021687|SSAR^SSA (Ro) AB^DYNA|||20240604084300-0400|||||||20240604084348-0400|^^^^|699999^ONLY^TEST^^^^^^DYNA|||9J6MU8QPE0|IMMUN|401106|20240604112001-0400|||P|^^||
OBX|1|NM|SSAR^SSA (Ro) AB^DYNA|401106|5.9|AI|< 1|H|||P|||20240604112001-0400
NTE|1|RS||RS^^DYNA^IM26
NTE|2|RS|The presence of SS/A (Ro) autoantibodies may be used as|RS^^DYNA^IM26
NTE|3|RS|an aid in the diagnosis of Sjogren's syndrome (especially|RS^^DYNA^IM26
NTE|4|RS|with vasculitis) and systemic lupus erythematosus (SLE)|RS^^DYNA^IM26
NTE|5|RS|with Sjogren's overlap syndrome.|RS^^DYNA^IM26
NTE|6|RS||RS^^DYNA^IM26
NTE|7|RF|Negative:  <1.0   AI|RF^^^
NTE|8|RF|Positive: >=1.0   AI|RF^^^
OBR|8|^Dynacare|5010021687|SSBL^SSB (La) AB^DYNA|||20240604084300-0400|||||||20240604084348-0400|^^^^|699999^ONLY^TEST^^^^^^DYNA|||9J6MU8QPE0|IMMUN|401107|20240604112036-0400|||P|^^||
OBX|1|NM|SSBL^SSB (La) AB^DYNA|401107|5.9|AI|< 1|H|||P|||20240604112036-0400
NTE|1|RS||RS^^DYNA^IM27
NTE|2|RS|The presence of SS/B (La) autoantibodies may be used as|RS^^DYNA^IM27
NTE|3|RS|an aid in the diagnosis of Sjogren's syndrome (especially|RS^^DYNA^IM27
NTE|4|RS|with vasculitis) and systemic lupus erythematosus (SLE)|RS^^DYNA^IM27
NTE|5|RS|with Sjogren's overlap syndrome.|RS^^DYNA^IM27
NTE|6|RS||RS^^DYNA^IM27
NTE|7|RF|Negative:  <1.0   AI|RF^^^
NTE|8|RF|Positive: >=1.0   AI|RF^^^
OBR|9|^Dynacare|5010021687|SMTH^SMITH AB^DYNA|||20240604084300-0400|||||||20240604084348-0400|^^^^|699999^ONLY^TEST^^^^^^DYNA|||9J6MU8QPE0|IMMUN|401108|20240604112058-0400|||P|^^||
OBX|1|NM|SMTH^SMITH AB^DYNA|401108|0.3|AI|< 1|N|||P|||20240604112058-0400
NTE|1|RF|Negative:  <1.0   AI|RF^^^
NTE|2|RF|Positive: >=1.0   AI|RF^^^
OBR|10|^Dynacare|5010021687|SCL7^SCL-70 AB^DYNA|||20240604084300-0400|||||||20240604084348-0400|^^^^|699999^ONLY^TEST^^^^^^DYNA|||9J6MU8QPE0|IMMUN|401111|20240604112106-0400|||P|^^||
OBX|1|TX|SCL7^SCL-70 AB^DYNA|401111|<0.2|AI|< 1|N|||P|||20240604112106-0400
NTE|1|RF|Negative:  <1.0   AI|RF^^^
NTE|2|RF|Positive: >=1.0   AI|RF^^^
OBR|11|^Dynacare|5010021687|JO1^JO-1 AB^DYNA|||20240604084300-0400|||||||20240604084348-0400|^^^^|699999^ONLY^TEST^^^^^^DYNA|||9J6MU8QPE0|IMMUN|401112|20240604112116-0400|||P|^^||
OBX|1|TX|JO1^JO-1 AB^DYNA|401112|<0.2|AI|< 1|N|||P|||20240604112116-0400
NTE|1|RF|Negative:  <1.0   AI|RF^^^
NTE|2|RF|Positive: >=1.0   AI|RF^^^
OBR|12|^Dynacare|5010021687|RNPA^RNP AB^DYNA|||20240604084300-0400|||||||20240604084348-0400|^^^^|699999^ONLY^TEST^^^^^^DYNA|||9J6MU8QPE0|IMMUN|401170|20240604112146-0400|||P|^^||
OBX|1|NM|RNPA^RNP AB^DYNA|401170|2.1|AI|< 1|H|||P|||20240604112146-0400
NTE|1|RS||RS^^DYNA^IM33
NTE|2|RS|This test measures IgG autoantibodies against RNP and is|RS^^DYNA^IM33
NTE|3|RS|used as an aid in the diagnosis of mixed connective|RS^^DYNA^IM33
NTE|4|RS|tissue disease.  These antibodies may also be present in|RS^^DYNA^IM33
NTE|5|RS|low frequencies in other rheumatic diseases including|RS^^DYNA^IM33
NTE|6|RS|Rheumatoid Arthritis and scleroderma.|RS^^DYNA^IM33
NTE|7|RS||RS^^DYNA^IM33
NTE|8|RF|AI|RF^^^
NTE|9|RF|Negative: <1.0 AI|RF^^^
NTE|10|RF|Positive: >=1.0 AI|RF^^^
OBR|13|^Dynacare|5010021687|634A^URINE CULTURE^DYNA|||20240604084300-0400|||||||20240604084348-0400|^^^^|699999^ONLY^TEST^^^^^^DYNA|||9J6MU8QPE0|MICRO|181000|20240604111403-0400|||P|^^||
OBX|1|TX|634A^URINE CULTURE^DYNA|181000|See Notes|||I|||P|||20240604111403-0400
NTE|1|RS|RESULTS FROM TESTING CEPHALOTHIN CAN BE USED TO|RS^^DYNA^CEPH
NTE|2|RS|REPRESENT THE OTHER ORAL CEPHALOSPORINS;CEPHALEXIN,|RS^^DYNA^CEPH
NTE|3|RS|CEFADROXIL AND CEFPODOXIME.|RS^^DYNA^CEPH
OBX|2|TX|CI^CIPROFLOXACIN^DYNA|181000.013.0002.001|SUSCEPTIBLE|||I|||P|||00010101000000-0500
OBX|3|TX|FU^NITROFURANTOIN^DYNA|181000.013.0002.002|SUSCEPTIBLE|||I|||P|||00010101000000-0500
OBX|4|TX|GE^GENTAMICIN^DYNA|181000.013.0002.003|SUSCEPTIBLE|||I|||P|||00010101000000-0500
OBX|5|TX|SE^TRIMETHOPRIM/SULFA^DYNA|181000.013.0002.004|SUSCEPTIBLE|||I|||P|||00010101000000-0500
OBX|6|TX|TO^TOBRAMYCIN^DYNA|181000.013.0002.005|SUSCEPTIBLE|||I|||P|||00010101000000-0500
OBX|7|TX|CV^AMOXICILLIN/CLAVULANIC ACID^DYNA|181000.013.0002.006|SUSCEPTIBLE|||I|||P|||00010101000000-0500
OBX|8|TX|AM^AMPICILLIN^DYNA|181000.013.0002.007|RESISTANT|||I|||P|||00010101000000-0500
OBX|9|TX|36^Escherichia coli^DYNA|181000.012.0001|Colony count: >100 x E6 cfu/L of|||I|||P|||20240604111403-0400
OBR|14|^Dynacare|5010021687|628T^THROAT SWAB C/S^DYNA|||20240604084300-0400|||||||20240604084348-0400|^^^^|699999^ONLY^TEST^^^^^^DYNA|||9J6MU8QPE0|MICRO|282000||||P|^^||
OBX|1|TX|40A^HAEMOLYTIC STREPTOCOCCI GROUP A^DYNA|282000.012.0001|Growth of|||I|||P|||20240604111513-0400
OBR|15|^Dynacare|5010021687|625A^VAGINA SWAB^DYNA|||20240604084300-0400|||||||20240604084348-0400|^^^^|699999^ONLY^TEST^^^^^^DYNA|||9J6MU8QPE0|MICRO|383000|20240604111617-0400|||F|^^||
OBX|1|TX|625A^VAGINA SWAB^DYNA|383000|See Notes|||I|||F|||20240604111617-0400
NTE|1|RS||RS^^DYNA^BV55
NTE|2|RS|Laboratory diagnosis of bacterial vaginosis has not|RS^^DYNA^BV55
NTE|3|RS|been validated for pre-pubescent and post-menopausal|RS^^DYNA^BV55
NTE|4|RS|patients. Please interpret such results in|RS^^DYNA^BV55
NTE|5|RS|the clinical context of the patient.|RS^^DYNA^BV55
OBX|2|TX|MICROC^MICROSCOPY^DYNA|383000.001|No  Trichomonas  vaginalis  seen. False negative                                  \.br\results for T.vaginalis may occur if microscopy is                                \.br\not performed immediately after specimen collection.                              \.br\|||N|||F|||20240604111617-0400
OBX|3|TX|MICROC^MICROSCOPY^DYNA|383000.002|YEAST PRESENT|||A|||F|||20240604111617-0400
OBX|4|TX|MICROC^MICROSCOPY^DYNA|383000.003|Gram smear is CONSISTENT with BACTERIAL VAGINOSIS.|||A|||F|||20240604111617-0400
OBR|16|^Dynacare|5010021687|PTVS^TRICH (NAAT-SWAB)^DYNA|||20240604084300-0400|||||||20240604084348-0400|^^^^|699999^ONLY^TEST^^^^^^DYNA|||9J6MU8QPE0|MICRO|383289|20240604111714-0400|||F|^^||
OBX|1|TX|PTVS^TRICH (NAAT-SWAB)^DYNA|383289|NON-DETECTED|||N|||F|||20240604111714-0400
NTE|1|RS||RS^^DYNA^TMND
NTE|2|RS|Result for Trichomonas vaginalis is NOT DETECTED (NEGATIVE).|RS^^DYNA^TMND
NTE|3|RS|Results should be interpreted by clinicians in the context|RS^^DYNA^TMND
NTE|4|RS|of the individual patient's current symptoms, medical history,|RS^^DYNA^TMND
NTE|5|RS|and risk profile to determine appropriate management.|RS^^DYNA^TMND
NTE|6|RS|Retesting may be warranted if results do not match clinical|RS^^DYNA^TMND
NTE|7|RS|picture and risk profile.|RS^^DYNA^TMND
NTE|8|RS||RS^^DYNA^TMVA
NTE|9|RS|The Aptima Trichomonas vaginalis Assay is a Health Canada|RS^^DYNA^TMVA
NTE|10|RS|approved qualitative nucleic acid amplification test|RS^^DYNA^TMVA
NTE|11|RS|(NAAT/TMA) for the diagnosis of trichomoniasis using the|RS^^DYNA^TMVA
NTE|12|RS|Hologic Panther System. This test is not currently licensed|RS^^DYNA^TMVA
NTE|13|RS|for use in patients under the age of 14 years, or for the|RS^^DYNA^TMVA
NTE|14|RS|evaluation of sexual abuse, or for other medico-legal|RS^^DYNA^TMVA
NTE|15|RS|investigations.|RS^^DYNA^TMVA
NTE|16|RF|Uro-Genital swab|RF^^^
OBR|17|^Dynacare|5010021687|253^URINALYSIS CHEMICAL^DYNA|||20240604084300-0400|||||||20240604084348-0400|^^^^|699999^ONLY^TEST^^^^^^DYNA|||9J6MU8QPE0|URIN|500000||||F|^^||
OBX|1|TX|GLUCU^GLUCOSE^DYNA|500000.021|NEG|mmol/L|NEGATIVE|N|||F|||20240604112256-0400
NTE|1|RF|NEGATIVE (mmol/L)|RF^^^
OBX|2|TX|BILIU^BILIRUBIN^DYNA|500000.022|NEG||NEGATIVE|N|||F|||20240604112256-0400
NTE|1|RF|NEGATIVE|RF^^^
OBX|3|TX|KET^KETONES^DYNA|500000.023|NEG|mmol/L|NEGATIVE|N|||F|||20240604112256-0400
NTE|1|RF|NEGATIVE (mmol/L)|RF^^^
OBX|4|NM|S/G^SPECIFIC GRAVITY^DYNA|500000.024|1.025||1.005 - 1.03|N|||F|||20240604112256-0400
NTE|1|RF|1.005 - 1.030|RF^^^
OBX|5|TX|BLDU^BLOOD^DYNA|500000.025|MODERATE||NEGATIVE|A|||F|||20240604112256-0400
NTE|1|RF|NEGATIVE|RF^^^
OBX|6|NM|UPH^pH^DYNA|500000.026|7.0||5 - 8|N|||F|||20240604112256-0400
NTE|1|RF|5.0 - 8.0|RF^^^
OBX|7|TX|PROTU^PROTEIN^DYNA|500000.027|NEG|g/L|NEGATIVE|N|||F|||20240604112256-0400
NTE|1|RF|NEGATIVE (g/L)|RF^^^
OBX|8|NM|UBG^UROBILINOGEN^DYNA|500000.028|16.|umol/L|3.2 - 16|N|||F|||20240604112256-0400
NTE|1|RF|3.2 - 16  umol/L|RF^^^
OBX|9|TX|NIT^NITRITE^DYNA|500000.029|NEG||NEGATIVE|N|||F|||20240604112256-0400
NTE|1|RF|NEGATIVE|RF^^^
OBX|10|TX|LEUK^LEUKOCYTES^DYNA|500000.030|LARGE||NEGATIVE|A|||F|||20240604112256-0400
NTE|1|RF|NEGATIVE|RF^^^
OBX|11|TX|UCOLOR^COLOUR^DYNA|500000.031|YELLOW||YELLOW|N|||F|||20240604112256-0400
NTE|1|RF|YELLOW|RF^^^
OBX|12|TX|APPEAU^APPEARANCE^DYNA|500000.032|HAZY||CLEAR|A|||F|||20240604112256-0400
NTE|1|RF|CLEAR|RF^^^
